Global Neurodegenerative Diseases Market 2015-2019

Jul 13, 2015, 19:28 ET from ReportBuyer

LONDON, July 13, 2015 /PRNewswire/ -- About neurodegenerative diseases
According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely debilitating. They result in progressive degeneration of nerve cells, causing them to die eventually. These diseases cause ataxia and dementia in people, which can have a serious impact on the mental health of patients. Some examples of neurodegenerative diseases are Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, and epilepsy. Huntington's disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimer's disease and Parkinson's disease which have a high degree of prevalence.
Technavio's analysts forecast the global neurodegenerative diseases market to grow at a CAGR of 4.77 percent over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases. The market includes data from the sales of various drugs used in the treatment of:
• Alzheimer's Disease
• Parkinson's Disease
• Multiple Sclerosis
• Epilepsy
• Huntington's Disease
• Amyotrophic Lateral Sclerosis
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the global neurodegenerative diseases market. The vendor landscape section includes a market share analysis of the major vendors along with the performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market. In addition, late-stage pipeline molecules developed for the treatment of neurodegenerative diseases are discussed.
Technavio's report, Global Neurodegenerative Diseases Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA, and the APAC; it also covers the global neurodegenerative diseases market landscape and its growth prospects in the coming years. The report also includes a discussion of the Key vendors ?operating in this market.
Key regions
• Americas

Key vendors

• Biogen Idec
• Merck Serono
• Novartis
• Pfizer
• Teva Pharmaceutical Industries

Other prominent vendors

• AB Science
• Abbvie
• Acorda Therapeutics
• Actavis
• Active Biotech
• Adamas Pharmaceuticals
• Akorn
• Archer Pharmaceuticals
• Astellas
• Auspex Pharmaceuticals
• Bayer
• Boehringer Ingelheim
• Covis
• Desitin Arzneimittel
• Eisai
• Eli Lilly
• Endo International
F. Hoffmann-La Roche
• FORUM Pharmaceuticals
• GlaxoSmithKline
• Glenmark
• H. Lundbeck
• Ipsen
• Janssen Pharmaceuticals
• Kyowa Hakko Kirin
• Mitsubishi Tanabe
• MorphoSys
• Newron Pharmaceuticals
• Omeros
• Opexa
• Orion
• Otsuka Pharmaceutical
• Oxford BioMedica
• Palobiofarma
• Prana Biotechnology
• Raptor Pharmaceutical
• Sanofi
• Siena Biotech
• SOM Biotech
• Takeda Pharmaceutical
• TauRx Pharmaceuticals
• US WorldMeds
• Valeant
• Zinfandel Pharmaceuticals
Market driver
• High unmet medical needs
• For a full, detailed list, view our report
Market challenge
• Generic erosion
• For a full, detailed list, view our report
Market trend
• Reformulation of marketed drugs
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the Key Market Trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the Key vendors ?in this market space?
• What are the market opportunities and threats faced by the Key vendors ?
• What are the strengths and weaknesses of the Key vendors ?


Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Companies Mentioned

Biogen, Merck Serono, Novartis, Pfizer, Teva Pharmaceutical, UCB SA, AB Science, Abbvie, Acorda Therapeutics, Actavis, Active Biotech, Adamas, Akorn, Archer, Astellas, Auspex, Bayer, Boehringer Ingelheim, Covis, Desitin Arzneimittel, Eli Lilly, Eisai, Endo International, F. Hoffmann-La Roche, FORUM, GlaxoSmithKline Glenmark, Lundbeck, Janssen Pharmaceuticals, Kyowa Hakko Kirin, Mitsubishi Tanabe, MorphoSys, Newron Pharmaceuticals, Omeros, Opexa, Orion, Otsuka, BioMedica, Palobiofarma, Prana Biotechnology, Raptor, Sanofi, Siena, SOM, STADA, Takeda Pharmaceutical, TauRx Pharmaceuticals, US WorldMeds, Valeant, Zinfandel
Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Tel: +44 208 816 85 48

SOURCE ReportBuyer